274. Comparison of Cefazolin Susceptibilities of Enterobacterales with an Automated Susceptibility Testing Platform versus In Vitro Antimicrobial Testing

BACKGROUND: The Clinical and Laboratory Standards Institute (CLSI) revised breakpoints for cefazolin (CFZ) may be difficult to implement with current automated susceptibility testing (AST) platforms and Enterobacterales may be falsely reported as susceptible to CFZ. The possibility remains that CFZ...

Descripción completa

Detalles Bibliográficos
Autores principales: Noval, Mandee, Heil, Emily, Williams, Paula, Johnson, J Kristie, Claeys, Kimberly C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777686/
http://dx.doi.org/10.1093/ofid/ofaa439.318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777686/
http://dx.doi.org/10.1093/ofid/ofaa439.318

Ejemplares similares